A “MIRACLE” drug which could help beat Alzheimer’s disease could be approved in the US next week and be available on the NHS in 2022.
Around one million Brits suffer from Alzheimer’s – a type of dementia which affects memory and thinking – which killed beloved Eastenders star Barbara Windsor.
Research shows that Aducanumab could slow mental decline in patients as it targets toxic proteins which damage brain cells.
According to the Mirror, US regulators the Food and Drug Administration (FDA) are set to approve the drug within days.
If greenlit the drug would be the first ever to work against the disease which was first discovered in 1906.
Current Alzheimer’s drugs only treat the symptoms, rather than the underlying cause.
And after US approval, it’s expected UK regulators would make the drug available on the NHS as early as next year.
Trial data is being studied to see whether Aducanumab slows down the decline in memory and language skills. .. Source